SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

BACKGROUND: Treatment for localized soft tissue sarcoma includes surgery and radiation, while the role of chemotherapy is controversial. Biomarkers that could predict therapeutic response or prognosticate overall survival (OS) are needed to define patients most likely to benefit from systemic treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Elizabeth J., Zhao, Lili, Lucas, David R., Schuetze, Scott M., Baker, Laurence H., Zalupski, Mark M., Thomas, Dafydd, Chugh, Rashmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992190/
https://www.ncbi.nlm.nih.gov/pubmed/27544129
http://dx.doi.org/10.1186/s12885-016-2694-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992190/
https://www.ncbi.nlm.nih.gov/pubmed/27544129
http://dx.doi.org/10.1186/s12885-016-2694-2

Ejemplares similares